While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) still rule the weight-loss drug market with their respective GLP-1 medications, competition could soon be heating up as rival products near ...

减肥药物赛道的竞争异常激烈，但华尔街对一家名为Viking Therapeutics（NASDAQ: ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C)-1.63% AT&T Inc. Dep. Pfd. (Rep. 1/1000th 5% Perp. Pfd. Series A)-1.97% ...

The NFL's decision to move the Rams-Vikings game marks just the second time the league's moved a playoff game in its 105-season history. While Monday's game is being moved for safety concerns ...

U.S. Marketscategory Wall St Week Ahead Tech sell-off jolts investors as jobs data looms February 2, 2025 U.S. Marketscategory Wall St ends lower as White House says Trump to implement tariffs ...